Overview Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser Status: Completed Trial end date: 2018-06-02 Target enrollment: Participant gender: Summary Long-term follow-up of patients with diabetic macular edema (DME) treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) combined focal laser and identification of prognostic morphological characteristics. Phase: Phase 4 Details Lead Sponsor: Hospital HietzingTreatments: BevacizumabEndothelial Growth FactorsPharmaceutical SolutionsRanibizumab